Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Clarisse Dromain"'
Autor:
Chiara Pozzessere, Bianca Mazini, Patrick Omoumi, Mario Jreige, Leslie Noirez, Antonia Digklia, François Fasquelle, Christine Sempoux, Clarisse Dromain
Publikováno v:
Cancers, Vol 16, Iss 14, p 2585 (2024)
Immunotherapy has revolutionized oncology care, improving patient outcomes in several cancers. However, these therapies are also associated with typical immune-related adverse events due to the enhanced inflammatory and immune response. These toxicit
Externí odkaz:
https://doaj.org/article/69c40a4bdd68468b93152185002781b0
Autor:
Perrine Courlet, Daniel Abler, Monia Guidi, Pascal Girard, Federico Amato, Naik Vietti Violi, Matthieu Dietz, Nicolas Guignard, Alexandre Wicky, Sofiya Latifyan, Rita De Micheli, Mario Jreige, Clarisse Dromain, Chantal Csajka, John O. Prior, Karthik Venkatakrishnan, Olivier Michielin, Michel A. Cuendet, Nadia Terranova
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 8, Pp 1170-1181 (2023)
Abstract The development of immune checkpoint inhibitors (ICIs) has revolutionized cancer therapy but only a fraction of patients benefits from this therapy. Model‐informed drug development can be used to assess prognostic and predictive clinical f
Externí odkaz:
https://doaj.org/article/8022c02f0e224911a18a052e668f5e9a
Autor:
Raphaël Girardet, Jean-François Knebel, Clarisse Dromain, Naik Vietti Violi, Georgia Tsoumakidou, Nicolas Villard, Alban Denys, Nermin Halkic, Nicolas Demartines, Kosuke Kobayashi, Antonia Digklia, Niklaus Schaefer, John O. Prior, Sarah Boughdad, Rafael Duran
Publikováno v:
Cancers, Vol 16, Iss 3, p 586 (2024)
Background: Factors affecting morphological changes in the liver following selective internal radiation therapy (SIRT) are unclear, and the available literature focuses on non-anatomical volumetric assessment techniques in a lobar treatment setting.
Externí odkaz:
https://doaj.org/article/813d52b904ab4931903a66296e76cc61
Autor:
Antonia M. Berz, Sarah Boughdad, Naïk Vietti-Violi, Antonia Digklia, Clarisse Dromain, Vincent Dunet, Rafael Duran
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
In recent years, a wide range of cancer immunotherapies have been developed and have become increasingly important in cancer treatment across multiple oncologic diseases. In particular, immune checkpoint inhibitors (ICIs) offer promising options to i
Externí odkaz:
https://doaj.org/article/b42a6d1d2066411d9d0d0a7b1b3c684c
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
In recent years, various systemic immunotherapies have been developed for cancer treatment, such as monoclonal antibodies (mABs) directed against immune checkpoints (immune checkpoint inhibitors, ICIs), oncolytic viruses, cytokines, cancer vaccines,
Externí odkaz:
https://doaj.org/article/0406dc0da0f04b48bcadabf07ed05a3d
Autor:
John Prior, Solange Peters, Krisztian Homicsko, Sarah Boughdad, Niklaus Schaefer, Antonia Digklia, Clarisse Dromain, Mounir Trimech, Ana Dolcan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Prostate-specific membrane antigen (PSMA)-targeted radioligand therapy is a validated treatment option for patients with advanced prostate cancer. Although PSMA expression is not limited to prostate tissue, little is known about its relevance to othe
Externí odkaz:
https://doaj.org/article/50a540258e4148daa7709fb78b369abc
Autor:
Bianca Gautron Moura, Camille L. Gerard, Nathalie Testart, Marian Caikovski, Alexandre Wicky, Veronica Aedo-Lopez, Grégoire Berthod, Krisztian Homicsko, John O. Prior, Clarisse Dromain, Lana E. Kandalaft, Michel A. Cuendet, Olivier Michielin
Publikováno v:
Cancers, Vol 15, Iss 1, p 31 (2022)
Combined ipilimumab and nivolumab significantly improve outcomes in metastatic melanoma patients but bear an important financial impact on the healthcare system. Here, we analyze the treatment costs, focusing on irAE. We conducted a retrospective ana
Externí odkaz:
https://doaj.org/article/3415957103b8466e9532cd8b162a1f62
Publikováno v:
European Radiology Experimental, Vol 4, Iss 1, Pp 1-15 (2020)
Abstract A wide range of cancer immunotherapy approaches has been developed including non-specific immune-stimulants such as cytokines, cancer vaccines, immune checkpoint inhibitors (ICIs), and adoptive T cell therapy. Among them, ICIs are the most c
Externí odkaz:
https://doaj.org/article/9ae914a4ff8d4f97b06e1c8e99b8e1a3
Autor:
Alice Boilève, Aline Maillard, Mathilde Wagner, Clarisse Dromain, Christophe Laurent, Eric Dupont Bierre, Samuel Le Sourd, Franck Audemar, Ayhan Ulusakarya, Veronique Guerin-Meyer, Denis Smisth, Veronica Pezzella, Thierry De Baere, Diane Goere, Maximiliano Gelli, Julien Taieb, Valérie Boige
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Approximately 40% of colorectal cancer patients will develop colorectal liver metastases (CRLM). The most effective approach to increase long-term survival is CRLM complete resection. Unfortunately, only 10–15% of CRLM are initi
Externí odkaz:
https://doaj.org/article/1b9a67d03fca4de59571a06ca821ec61
Autor:
Clarisse Dromain, Marianne E. Pavel, Philippe Ruszniewski, Alison Langley, Christine Massien, Eric Baudin, Martyn E. Caplin, on behalf of the CLARINET Study Group
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Lanreotide depot/autogel antitumor activity in intestinal/pancreatic neuroendocrine tumors (NETs) was demonstrated in the phase-3 CLARINET study (NCT00353496), based on significantly prolonged progression-free survival (PFS) versu
Externí odkaz:
https://doaj.org/article/1f795cec730848fe9592f8ceb1c701b4